48
Participants
Start Date
December 5, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
November 30, 2024
Clopidogrel 75 mg
Clopidogrel 75 mg tablet
Tegoprazan 25 mg
Tegoprazan 25 mg tablet
Esomeprazole 20mg
Esomeprazole 20 mg tablet
Seoul National University Hospital, Clinical Trial Center, Seoul
Lead Sponsor
HK inno.N Corporation
INDUSTRY